Delivery timing in dichorionic diamniotic twin pregnancies complicated by preeclampsia: a decision analysis

Bethany T. Waites, Allison R. Walker, A. Caughey
{"title":"Delivery timing in dichorionic diamniotic twin pregnancies complicated by preeclampsia: a decision analysis","authors":"Bethany T. Waites, Allison R. Walker, A. Caughey","doi":"10.1080/14767058.2022.2053103","DOIUrl":null,"url":null,"abstract":"Abstract Objective To determine the optimal timing of delivery in Dichorionic-diamniotic (DCDA) pregnancies complicated by preeclampsia without severe features. Methods A decision-analytic model was created to compare outcomes of expectant management vs. delivery from 34 to 37w0d. Outcomes included quality-adjusted life years (QALYs), development of severe preeclampsia, maternal mortality, maternal stroke, small for gestational age (SGA) due to fetal growth restriction (FGR) detected antenatally, stillbirth, cerebral palsy (CP), and neonatal mortality. Probabilities, utilities, and life expectancies were derived from the literature. Univariate analysis was used to evaluate the impact of delivery at various gestational ages. Maternal and neonatal outcomes were calculated for a theoretical cohort of 10,000 DCDA pregnancies with preeclampsia. Results The optimal gestational age for delivery was 36w0d when the total QALYs (868,112) were highest. Delivery at 34w0d resulted in the fewest cases of severe preeclampsia, maternal mortality, and maternal stroke (0, 4, and 15 cases per 10,000, respectively). The incidence of each of these adverse outcomes increased with gestational age, with the greatest number of adverse outcomes at 37w0d (2452 cases of severe preeclampsia, eight maternal deaths, and 31 cases of maternal stroke per 10,000). Delivery at 34w0d resulted in the fewest cases of severe preeclampsia (0), maternal stroke (15), maternal mortality (4), stillbirth (0), and SGA (1183). However, this strategy was also associated with most cases of neonatal CP (91) and neonatal mortality (87). Conclusion DCDA twin pregnancies complicated by preeclampsia without severe features appear to have the best outcomes when delivered at 36w0d. Specifically, when compared to delivery at 37w0d, this strategy reduced maternal and neonatal morbidity and mortality.","PeriodicalId":22921,"journal":{"name":"The Journal of Maternal-Fetal & Neonatal Medicine","volume":"1 1","pages":"9780 - 9785"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Maternal-Fetal & Neonatal Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/14767058.2022.2053103","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Abstract Objective To determine the optimal timing of delivery in Dichorionic-diamniotic (DCDA) pregnancies complicated by preeclampsia without severe features. Methods A decision-analytic model was created to compare outcomes of expectant management vs. delivery from 34 to 37w0d. Outcomes included quality-adjusted life years (QALYs), development of severe preeclampsia, maternal mortality, maternal stroke, small for gestational age (SGA) due to fetal growth restriction (FGR) detected antenatally, stillbirth, cerebral palsy (CP), and neonatal mortality. Probabilities, utilities, and life expectancies were derived from the literature. Univariate analysis was used to evaluate the impact of delivery at various gestational ages. Maternal and neonatal outcomes were calculated for a theoretical cohort of 10,000 DCDA pregnancies with preeclampsia. Results The optimal gestational age for delivery was 36w0d when the total QALYs (868,112) were highest. Delivery at 34w0d resulted in the fewest cases of severe preeclampsia, maternal mortality, and maternal stroke (0, 4, and 15 cases per 10,000, respectively). The incidence of each of these adverse outcomes increased with gestational age, with the greatest number of adverse outcomes at 37w0d (2452 cases of severe preeclampsia, eight maternal deaths, and 31 cases of maternal stroke per 10,000). Delivery at 34w0d resulted in the fewest cases of severe preeclampsia (0), maternal stroke (15), maternal mortality (4), stillbirth (0), and SGA (1183). However, this strategy was also associated with most cases of neonatal CP (91) and neonatal mortality (87). Conclusion DCDA twin pregnancies complicated by preeclampsia without severe features appear to have the best outcomes when delivered at 36w0d. Specifically, when compared to delivery at 37w0d, this strategy reduced maternal and neonatal morbidity and mortality.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
双绒毛膜双羊膜双胎合并先兆子痫的分娩时机:决策分析
【摘要】目的探讨双绒毛膜-双羊膜血症(DCDA)妊娠合并子痫前期无严重症状的最佳分娩时机。方法建立决策分析模型,比较34 ~ 37天待产与分娩的结局。结果包括质量调整生命年(QALYs)、重度先兆子痫的发生、孕产妇死亡率、孕产妇卒中、因胎儿生长受限(FGR)导致的胎龄过小(SGA)、死产、脑瘫(CP)和新生儿死亡率。概率、效用和预期寿命均来自文献。采用单因素分析评估不同胎龄分娩的影响。对10000例DCDA妊娠伴有先兆子痫的产妇和新生儿结局进行了理论队列计算。结果最佳胎龄为36龄,总QALYs(868,112)最高。34岁分娩导致严重先兆子痫、产妇死亡率和产妇中风的病例最少(分别为0例、4例和15例/ 10,000)。这些不良后果的发生率随着胎龄的增加而增加,37胎龄时不良后果的发生率最高(每10,000例中有2452例严重先兆子痫,8例产妇死亡和31例产妇中风)。34岁分娩导致的严重先兆子痫(0例)、产妇中风(15例)、产妇死亡(4例)、死产(0例)和SGA(1183例)病例最少。然而,这种策略也与大多数新生儿CP病例(91例)和新生儿死亡率(87例)有关。结论DCDA双胎妊娠合并无严重特征的子痫前期患儿在36龄分娩时预后最佳。具体而言,与37岁分娩相比,该策略降低了孕产妇和新生儿的发病率和死亡率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The impact of specialty training and physician attitudes on fetal cardiac counseling Fetoplacental unit involvement in uric acid production in women with severe preeclampsia: a prospective case control pilot study. Causal association of sex hormone-binding globulin on gestational hypertension and pre-eclampsia: a two-sample Mendelian randomization study Targeted metabolomic analysis of early-trimester serum identifies potential mechanisms for late-onset preeclampsia Statement of retraction: effect of daily consumption of probiotic yoghurt on lipid profiles in pregnant women: a randomized controlled clinical trial
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1